trending Market Intelligence /marketintelligence/en/news-insights/trending/s2dojunrdu_hlwmsppjlug2 content esgSubNav
In This List

Egalet CFO resigns

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Egalet CFO resigns

Egalet Corp. said Stanley Musial resigned as CFO and executive vice president, effective Nov. 9, in order to pursue other opportunities.

Musial was appointed as CFO of the Wayne, Pa.-based pharmaceutical company in April 2013 and has served as executive vice president since December 2015.

Egalet plans to sign a consulting agreement with Musial for a period of time after his employment ends.

Egalet develops pharmaceutical pain products. It markets Sprix, an anti-inflammatory nasal spray, and opioid pain relief medication Oxaydo.